[Effect of 6-azauridine-triacetate on the enzyme activity in psoriatic patients].
D001119:Arginase / Q000378:metabolism; D004798:Enzymes / Q000378:metabolism*; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood / Q000378:metabolism; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood / Q000378:metabolism; D008291:Malate Dehydrogenase / Q000097:blood / Q000378:metabolism; D011565:Psoriasis / Q000188:drug therapy / Q000201:enzymology*; D012867:Skin / Q000201:enzymology; D014227:Triazines / Q000627:therapeutic use*; D014508:Urea / Q000097:blood
D004798:Enzymes; D014227:Triazines; D014508:Urea; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D001119:Arginase; D005634:Fructose-Bisphosphate Aldolase
Vliv 6-azauridin-triacetátu na enzymatickou aktivitu u psoriatických pacientů.